Clinical Trials Logo

Clinical Trial Details — Status: Not yet recruiting

Administrative data

NCT number NCT05301452
Other study ID # ILIBSleepBruxism
Secondary ID
Status Not yet recruiting
Phase Phase 2
First received
Last updated
Start date October 1, 2022
Est. completion date November 1, 2023

Study information

Verified date August 2022
Source University of Nove de Julho
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Background: The objective of this study will be to evaluate the effect of Intravascular Irradiation of Blood (ILIB) combined with myofunctional exercises for sleep bruxism in pediatrics. Methods: This study will be a randomized controlled clinical trial. A triage of individuals between 4 and 17 years old with a diagnosis of sleep bruxism will be carried out at the clinic of the Catholic University of Uruguay, and in a private office referred by different private care centers. The selected participants will be evaluated before and after treatment by means of questionnaires on bruxism, sleep quality and nocturnal oxygen saturation measurement. For this, 46 patients with sleep bruxism will be recruited, who will be divided into 2 groups: control group (CG), which will undergo an application of placebo ILIB and an orofacial myofunctional therapy (MFT) exercise protocol; and na ILIB group, which will carry out an active application of ILIB and an exercise protocol, this being once a week for 8 weeks. The laser treatment (808 nm) will be performed twice a week for 8 weeks. The values will be tested for normality by the Kolmogorov-Smirnov test. For the comparison between the groups, T-test will be carried out, considering a level of significance of 0.5% (p<0.05). Discussion: Although local photobiomodulation (PBM), acupuncture PBM and physiotherapy have been studied in the treatment of bruxism, this is the first study to evaluate the effect of ILIB combined with myofunctional exercises for sleep bruxism in pediatrics.


Recruitment information / eligibility

Status Not yet recruiting
Enrollment 46
Est. completion date November 1, 2023
Est. primary completion date June 20, 2023
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 4 Years to 17 Years
Eligibility Inclusion Criteria: - in the mixed dentition phase (permanent incisors and first molars erupted); - adolescents with an established permanent dentition. Exclusion Criteria: - People with dental caries; - Those taking medications, such as inflammatory agents, muscle relaxants, corticosteroids, anticonvulsants, and antidepressants; - Those with chronic diseases that affect muscles or motor coordination, and those who do not cooperate during the evaluation will be excluded from the study; - Children with cerebral palsy; - Patients whose guardians do not sign the informed consent or the user does not sign the assent.

Study Design


Related Conditions & MeSH terms


Intervention

Radiation:
Intravascular Irradiation of Blood (ILIB)
The laser treatment will be performed by a speech therapist and will have the following parameters: wavelength of 808 nm. It will be done twice a week for 8 weeks, in 20-minute sessions.
Placebo Intravascular Irradiation of Blood (ILIB)
The photobiomodulation procedure will be simulated, but with the laser turned off. It will be done twice a week for 8 weeks, in 20-minute sessions.
Procedure:
Orofacial Myofunctional Therapy
Myofunctional therapy will be performed by a speech therapist specialized in the area. It will consist of 1 weekly session, where the functions of breathing, chewing and swallowing will be evaluated and addressed. The following exercises will be indicated: nasal hygiene, inflated cheeks with the tip of the tongue on the palate, lingual sweep, tongue thrust against the palate, tongue touch on the last molars, chewing of soft solids and bolus assembly (20 minute therapy session).

Locations

Country Name City State
n/a

Sponsors (1)

Lead Sponsor Collaborator
University of Nove de Julho

Outcome

Type Measure Description Time frame Safety issue
Primary Changes in Oximetry A portable pulse oximeter that includes Masimo SET® Measure-through Motion and Low Perfusion™ pulse oximetry under motion and low perfusion conditions will be used. Nocturnal oximetry will be performed prior to treatment and post treatment. The parents or guardians of the minor will be trained. Baseline and 8 weeks of treatment.
Secondary Changes in Breathing A clinical evaluation will be carried out by a speech therapist specialized in the area of Orofacial Motricity, to check for possible improvement in breathing. It is the respiratory characterization from the taking of air, which explains the anatomical and topographical situation of its entrance to the respiratory system (respiratory mode), to the thoracoabdominal movement zone that integrates inspiration and expiration. It is supported by the observation with the aid of a Glatzel's mirror to anatomically determine the upper airway status and its functional correlation. Baseline and 8 weeks of treatment.
Secondary Changes in Swallowing A clinical evaluation will be carried out by a speech therapist specialized in the area of Orofacial Motricity, to check for possible improvement in swallowing. For this, the Payne's test, which assesses tongue posture both at rest and in function (swallowing), will be used. From instruments such as liquid fluorescein applied to the apex lingual and lateral borders, and Payne's lamp that verifies the vestige of the fluroscein, and therefore the conditions of support, thrust, position and/or obstruction of the tongue. Baseline and 8 weeks of treatment.
Secondary Changes in Chewing A clinical evaluation will be carried out by a speech therapist specialized in the area of Orofacial Motricity, to check for possible improvement in chewing. For this, the gnatodynamometer, test that allows to measure the force of the occlusion, will be used. Baseline and 8 weeks of treatment.
Secondary Changes in Speech A clinical evaluation will be carried out by a speech therapist specialized in the area of Orofacial Motricity, to check for possible improvement in speech. For this, the Glatzel test will be used to measure the degree of nasal patency and the functional symmetry of the upper airways both at rest and in function. Specifically in the functional evaluation, its usefulness is linked to the verification of the existence of nasality or hyponasality before vowels elicited by the patient. Baseline and 8 weeks of treatment.
Secondary Changes in the Presence of Bruxism The bruxism questionnaire will be delivered to parents or guardians, which will be completed prior to treatment and afterwards. The questionnaire contains 4 questions regarding the perceived presence of bruxism, and 5 questions for the dentist to answer, based on a clinical observation. All questions have the options "yes" or "no". The more times the word "yes" is chosen, the greater the risk for bruxism is. Baseline and 8 weeks of treatment.
Secondary Changes in Sleep Quality A Pediatric Sleep Quality Questionnaire will be delivered to parents or guardians, and it will be completed prior to treatment and afterwards. The questionnaire contains 44 questions regarding sleep quality. All questions have the options "yes" or "no". The more times the word "yes" is chosen, the worse is the sleep quality. Baseline and 8 weeks of treatment.
See also
  Status Clinical Trial Phase
Terminated NCT03522207 - Accuracy and Efficacy of Trazodone (Desyrel) on Sleep Quality and Pain Management of TMD Patient Phase 4
Completed NCT02340663 - Nocturnal Mouth Guards, SOVA vs. Standard Acrylic Orthotic; Phase IV N/A
Recruiting NCT06153810 - Efficacy of AesyBite Active in Reducing Sleep Bruxism Activity N/A
Completed NCT03325920 - Validation of a Diagnostic Method for Quantification of Sleep Bruxism N/A
Not yet recruiting NCT05784454 - Prevalance of Sleep Bruxism Among a Group of Egyptian Children
Completed NCT02410681 - Sleep Bruxism and (Peri-)Implant Complications
Recruiting NCT01336439 - Effects of Botulinum Toxin Type A(Meditoxin®) on Sleep Bruxism Phase 4
Completed NCT01255878 - Comparative Evaluation of Gabapentine and Occlusal Splint in the Management of Sleep Bruxism N/A
Not yet recruiting NCT04211870 - Effects of Photobiomodulation in Children With Down Syndrome and Possible Sleep Bruxism Phase 1/Phase 2
Not yet recruiting NCT02757261 - Evaluation of Muscle Activity, Bite Force and Salivary Cortisol in Children With Bruxism Phase 0
Enrolling by invitation NCT04937036 - Impact of Bruxism Related Arousals on Cardiovascular Risk in Co-morbid Insomnia and Sleep Apnea
Completed NCT02882880 - Treatment Sleep Bruxism With the Luco Hybrid OSA Appliance N/A
Withdrawn NCT04078074 - Occlusal Stabilization Splints and Sleep Disordered Breathing N/A
Completed NCT01178229 - Physiotherapy on the Airway of Bruxist Children Phase 1/Phase 2
Completed NCT03766477 - Aspects Associated With Sleep Quality
Recruiting NCT06343194 - Changes in Electromyographic Activity in Aligner Treatment of Adult Patients With and Without Nocturnal Bruxism N/A
Completed NCT03039985 - All-ceramic Crowns in Patients With Sleep Bruxism N/A
Enrolling by invitation NCT04214561 - Relationship Between Selected Parameters and Bruxism
Recruiting NCT06214637 - Effectiveness of Melissa Officinalis for the Treatment of Probable Sleep Bruxism in Children and Adolescents Phase 1
Enrolling by invitation NCT03083405 - Selected Disorders and Sleep Bruxism